| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59.4M | — | +13.3% |
| Cost of Revenue | $16.0M | — | +12.9% |
| Gross Profit | $43.4M | — | +13.4% |
| R&D Expense | $2.2M | — | -5.1% |
| SG&A Expense | $31.0M | — | +2.5% |
| Operating Income | -$8.3M | — | +24.1% |
| Interest Expense | $1.7M | — | +32.5% |
| Pre-tax Income | -$10.9M | — | -3.8% |
| Income Tax | -$171K | — | -187.2% |
| Net Income | -$10.7M | — | -0.3% |
| EPS (Basic) | -$0.45 | — | +2.2% |
| EPS (Diluted) | -$0.45 | — | +2.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.2M | -37.7% | -63.5% |
| Short-term Investments | $36.6M | -11.3% | +44.5% |
| Accounts Receivable | $54.4M | +1.1% | +23.7% |
| Inventory | $134.0M | +0.2% | +11.9% |
| Current Assets | $245.9M | -4.1% | +5.9% |
| Total Assets | $502.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | +20.9% |
| Capital Expenditures | $1.8M | — | -58.4% |
| Investing Cash Flow | -$3.8M | — | +36.7% |
| Financing Cash Flow | -$614K | — | -387.3% |
| Free Cash Flow | -$5.0M | — | +39.8% |
| +6.8% |
| Current Liabilities | $47.2M | +2.1% | +25.8% |
| Long-term Debt | $106.7M | +0.6% | +37.8% |
| Total Liabilities | $163.5M | +0.9% | +32.8% |
| Stockholders' Equity | $338.7M | -2.3% | -2.4% |